When delivered in the subjective morning as MGMT abundance declined from its peak, a 100 μM dose of TMZ induced an additional 25–35% GBM cell death compared to delivering in the subjective afternoon/evening when MGMT abundance was low and beginning to increase (Figs. 2, S4, S7). The gene discussed is MGMT; the disease is glioblastoma.